Literature DB >> 25064178

Descending modulation of pain: the GABA disinhibition hypothesis of analgesia.

Benjamin K Lau1, Christopher W Vaughan2.   

Abstract

Within the central nervous system, descending systems exist to endogenously modulate our perception of pain. Of particular interest is a descending pathway which projects via the midbrain periaqueductal grey (PAG) and rostral ventromedial medulla (RVM) to inhibit ascending nociceptive transmission at the spinal cord dorsal horn. This descending PAG-RVM system forms the circuitry that underlies the physiological phenomenon of stress-induced analgesia (SIA), which is mediated by parallel opioid and cannabinoid neurotransmitter systems in the PAG. At the cellular level, opioids and cannabinoids are hypothesised to activate descending analgesia through an indirect process of 'GABA disinhibition'-suppression of inhibitory GABAergic inputs onto output neurons which constitute the descending analgesic pathway. While there is much indirect evidence to support disinhibition, there are still questions regarding this model that remain unaddressed. Furthermore, there is growing evidence suggesting more complex models than originally proposed. Crown
Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25064178     DOI: 10.1016/j.conb.2014.07.010

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  78 in total

1.  Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats.

Authors:  Marek Zubrzycki; Anna Janecka; Andreas Liebold; Mechthild Ziegler; Maria Zubrzycka
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

2.  Mechanism Underlying the Analgesic Effect Exerted by Endomorphin-1 in the rat Ventrolateral Periaqueductal Gray.

Authors:  Tao Chen; Jing Li; Ban Feng; Rui Hui; Yu-Lin Dong; Fu-Quan Huo; Ting Zhang; Jun-Bin Yin; Jian-Qing Du; Yun-Qing Li
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

Review 3.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

Review 4.  Cannabinoids in the descending pain modulatory circuit: Role in inflammation.

Authors:  Courtney A Bouchet; Susan L Ingram
Journal:  Pharmacol Ther       Date:  2020-01-29       Impact factor: 12.310

Review 5.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 6.  Endogenous opioid peptides in the descending pain modulatory circuit.

Authors:  Elena E Bagley; Susan L Ingram
Journal:  Neuropharmacology       Date:  2020-05-15       Impact factor: 5.250

Review 7.  Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.

Authors:  Henry L Blanton; Jennifer Brelsfoard; Nathan DeTurk; Kevin Pruitt; Madhusudhanan Narasimhan; Daniel J Morgan; Josée Guindon
Journal:  Drugs       Date:  2019-06       Impact factor: 9.546

8.  Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.

Authors:  Karin R Aubrey; Geoffrey M Drew; Hyo-Jin Jeong; Benjamin K Lau; Christopher W Vaughan
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

9.  Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression.

Authors:  Yu-Cheng Ho; Tzer-Bin Lin; Ming-Chun Hsieh; Cheng-Yuan Lai; Dylan Chou; Yat-Pang Chau; Gin-Den Chen; Hsien-Yu Peng
Journal:  Neuropsychopharmacology       Date:  2017-08-30       Impact factor: 7.853

10.  Toll-like Receptor 4 Mediates Morphine-Induced Neuroinflammation and Tolerance via Soluble Tumor Necrosis Factor Signaling.

Authors:  Lori N Eidson; Kiyoshi Inoue; Larry J Young; Malu G Tansey; Anne Z Murphy
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.